Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

SELL
$372.0 - $424.34 $1.49 Million - $1.69 Million
-3,994 Reduced 88.81%
503 $207,000
Q1 2024

May 08, 2024

SELL
$284.87 - $413.31 $32,475 - $47,117
-114 Reduced 2.47%
4,497 $1.82 Million
Q4 2023

Feb 08, 2024

SELL
$227.52 - $312.68 $1.18 Million - $1.62 Million
-5,185 Reduced 52.93%
4,611 $1.41 Million
Q3 2023

Nov 07, 2023

SELL
$233.98 - $281.67 $172,209 - $207,309
-736 Reduced 6.99%
9,796 $2.37 Million
Q2 2023

Aug 10, 2023

SELL
$187.26 - $240.17 $4.59 Million - $5.88 Million
-24,500 Reduced 69.94%
10,532 $2.53 Million
Q1 2023

May 10, 2023

BUY
$174.31 - $239.52 $4.66 Million - $6.4 Million
26,717 Added 321.31%
35,032 $6.59 Million
Q4 2022

Feb 09, 2023

SELL
$153.06 - $226.57 $1.02 Million - $1.51 Million
-6,665 Reduced 44.49%
8,315 $1.77 Million
Q3 2022

Nov 09, 2022

BUY
$145.13 - $182.49 $261,814 - $329,211
1,804 Added 13.69%
14,980 $2.35 Million
Q2 2022

Aug 09, 2022

SELL
$130.2 - $168.03 $16,535 - $21,339
-127 Reduced 0.95%
13,176 $1.97 Million
Q1 2022

May 06, 2022

BUY
$138.87 - $214.31 $553,119 - $853,596
3,983 Added 42.74%
13,303 $2.18 Million
Q4 2021

Feb 09, 2022

BUY
$182.74 - $227.9 $62,314 - $77,713
341 Added 3.8%
9,320 $2.03 Million
Q2 2021

Aug 11, 2021

SELL
$158.62 - $194.3 $134,985 - $165,349
-851 Reduced 8.66%
8,979 $1.59 Million
Q1 2021

May 03, 2021

SELL
$132.02 - $168.26 $243,180 - $309,934
-1,842 Reduced 15.78%
9,830 $1.61 Million
Q4 2020

Feb 09, 2021

SELL
$109.38 - $149.19 $13,453 - $18,350
-123 Reduced 1.04%
11,672 $1.63 Million
Q3 2020

Nov 04, 2020

SELL
$92.95 - $130.61 $369,104 - $518,652
-3,971 Reduced 25.19%
11,795 $1.32 Million
Q2 2020

Aug 07, 2020

BUY
$68.08 - $95.68 $500,932 - $704,013
7,358 Added 87.51%
15,766 $1.47 Million
Q1 2020

May 08, 2020

BUY
$61.71 - $101.95 $518,857 - $857,195
8,408 New
8,408 $617,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.8B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Great Lakes Advisors, LLC Portfolio

Follow Great Lakes Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Lakes Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Lakes Advisors, LLC with notifications on news.